Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Hair transplantation improves life quality by addressing scars, aging, and genetic flaws, but is limited by the availability of the patient's own hair for donation.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

A botanical extract may help manage hair loss from chemotherapy by preventing cell death in hair follicles.

Dr. Vogel improved hair restoration by reducing and recycling hair plugs, achieving a more natural look and a 50-80% survival rate for replanted follicles. He emphasized understanding natural hair loss patterns, educating patients about alopecia, and refusing to operate on those who don't understand these aesthetics.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Two cases of a rare skin condition were successfully treated with laser therapy, offering a non-surgical treatment option.

Using the drugs AMD3100 and Tacrolimus together greatly improves skin healing and hair growth after a deep skin cut by increasing stem cells in the wound.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Platelet-rich Plasma Gel may help treat en coup de sabre scleroderma, improving symptoms and skin quality with minimal side effects.

Ritlecitinib is effective and safe for treating alopecia areata, especially in newer cases.

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

Scalp reduction gives the most natural result for significant crown baldness, despite potential complications, and a systematic approach to surgical hair restoration results in few complications and high graft survival.

AI and new therapies show promise in medicine, especially for cancer and regenerative treatments.

Recognizing RSCC is crucial due to its aggressive nature and high risk of poor outcomes.

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

Treating acute myeloid leukemia is challenging, especially in older adults, despite some advancements.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Follicular unit hair transplantation is better than Miniflap Hair Restoration due to less scarring and more natural results.

The article discusses how to fix bad results from hair restoration surgery, with different doctors suggesting methods like adding more grafts, moving transplanted hair, or using smaller grafts.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

Keratinocyte Growth Factor-Hair Serum may help prevent hair loss during chemotherapy, but more research is needed.

The SAFE System for hair transplants results in low damage to follicles and could make the procedure suitable for more patients.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

308 nm excimer lamp therapy is effective for alopecia areata but less so for severe cases.

Rapamycin increased survival in mice with severe chronic graft-versus-host disease by expanding regulatory T cells.

Surgical hair restoration involves moving hair from a non-balding area to a balding area, with the transplanted hair not subject to male pattern baldness. Medications can slow hair loss and regrow some hair, but successful treatment needs careful planning, skill, and ethical responsibility due to progressive hair loss and limited donor hair.